Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Polycystic Ovary Syndrome 2Fatty Liver 2Diabetes Mellitus 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Obesity 1Neoplasms 1Lymphoma 1Iron Overload 1Hemoglobinopathies 1Glucose Metabolism Disorders 1Glucose Intolerance 1Fibrous Dysplasia, Polyostotic 1Fibrous Dysplasia of Bone 1

Interventions

Surveys and Questionnaires 86Blood Specimen Collection 58Interviews as Topic 28Observation 15Data Collection 15Radiotherapy 12Watchful Waiting 11Magnetic Resonance Spectroscopy 11Hematologic Tests 11Exercise 11Drug Therapy 11Quality of Life 9Biopsy 8Specimen Handling 7Therapeutics 6Restraint, Physical 6Magnetic Resonance Imaging 6Focus Groups 6pembrolizumab 5Standard of Care 5Rivaroxaban 5Phlebotomy 5Nivolumab 5Lapatinib 5Immune Checkpoint Inhibitors 5atezolizumab 4apixaban 4Trastuzumab 4Patient Reported Outcome Measures 4Palliative Care 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neoplasms × Glucose Tolerance Test × Clear all
NCT03415139 2022-03-28

Finding the Cause for Post-Transplant Diabetes Mellitus After Allogeneic Hematopoietic Cell Transplant

Vanderbilt-Ingram Cancer Center

Unknown
120 enrolled

Diabetes Mellitus, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡